| review article | Q7318358 |
| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1111/AOGS.13047 |
| P698 | PubMed publication ID | 27779757 |
| P50 | author | Eduardo Bernabé | Q37392884 |
| P2093 | author name string | Bo Jacobsson | |
| Erik Iwarsson | |||
| Thomas Davidson | |||
| Jessica Dagerhamn | |||
| Marianne Heibert Arnlind | |||
| P2860 | cites work | DNA Sequencing versus Standard Prenatal Aneuploidy Screening | Q22250872 |
| Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
| The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews | Q24801517 | ||
| Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center | Q27007785 | ||
| Assessing variability in results in systematic reviews of diagnostic studies | Q27314849 | ||
| Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis | Q28072788 | ||
| Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing | Q28742844 | ||
| GRADE guidelines: 3. Rating the quality of evidence | Q29547891 | ||
| The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. | Q30250029 | ||
| DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study | Q30414408 | ||
| Combining classifiers for robust PICO element detection | Q33578412 | ||
| DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study | Q34029044 | ||
| Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort | Q34088575 | ||
| Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing | Q34256640 | ||
| Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. | Q34340985 | ||
| Pregnancy: Prepare for unexpected prenatal test results | Q34479149 | ||
| Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study | Q34482155 | ||
| Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies | Q34496747 | ||
| High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma | Q34618332 | ||
| Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis | Q35209735 | ||
| Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis | Q35552815 | ||
| Digital PCR for the molecular detection of fetal chromosomal aneuploidy | Q35916813 | ||
| Screening for fetal aneuploidies at 11 to 13 weeks | Q37826399 | ||
| Invasive procedures for prenatal diagnosis: any future left? | Q38022987 | ||
| Simplifying the ultrasound findings of the major fetal chromosomal aneuploidies | Q38252690 | ||
| Initial experience with non-invasive prenatal testing of cell-free DNA for major chromosomal anomalies in a clinical setting | Q38419642 | ||
| Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. | Q40028555 | ||
| Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. | Q41566460 | ||
| Interpretation of random effects meta-analyses. | Q43810883 | ||
| Noninvasive prenatal testing for whole fetal chromosomal aneuploidies: a multicenter prospective cohort trial in Taiwan | Q44576378 | ||
| Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. | Q45026733 | ||
| Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors | Q46446186 | ||
| Cell-free DNA analysis for noninvasive examination of trisomy | Q46784231 | ||
| Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing | Q46816545 | ||
| The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. | Q47372679 | ||
| Non-invasive prenatal testing for trisomy 21 based on analysis of cell-free fetal DNA circulating in the maternal plasma. | Q51012348 | ||
| Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: a collaborative study in Europe. | Q51142138 | ||
| Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. | Q51321305 | ||
| Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. | Q51349861 | ||
| Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. | Q53599894 | ||
| A robust second-generation genome-wide test for fetal aneuploidy based on shotgun sequencing cell-free DNA in maternal blood | Q56986865 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: initial experience in a Chinese hospital | Q57177380 | ||
| P433 | issue | 1 | |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 7-18 | |
| P577 | publication date | 2016-10-25 | |
| P1433 | published in | Acta Obstetricia et Gynecologica Scandinavica | Q4676737 |
| P1476 | title | Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis | |
| P478 | volume | 96 |
| Q43083929 | A case of placental trisomy 18 mosaicism causing a false negative NIPT result |
| Q88983080 | Actividades preventivas en la mujer. Actualización PAPPS 2018 |
| Q48201332 | An incidental finding of maternal multiple myeloma by non invasive prenatal testing. |
| Q89660275 | Cell-Free Fetal DNA Increases Prior to Labor at Term and in a Subset of Preterm Births |
| Q48110029 | Comparison of first-tier cell-free DNA screening for common aneuploidies with conventional publically funded screening |
| Q47296123 | Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review. |
| Q64969403 | Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies. |
| Q64232954 | Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment |
| Q64068885 | Prenatal Sacrococcygeal Teratoma Diagnosed in a Fetus with Partial Trisomy 13q22 |
| Q90259969 | Prenatal cell-free DNA screening test failures: a systematic review of failure rates, risks of Down syndrome, and impact of repeat testing |
| Q90461658 | Result of Prospective Validation of the Trisomy Test® for the Detection of Chromosomal Trisomies |
| Q60912472 | The value of non-invasive prenatal testing: preferences of Canadian pregnant women, their partners, and health professionals regarding NIPT use and access |
| Q92092579 | [Noninvasive prenatal genetic testing in 6804 pregnant women aged less than 35 years with positive results in serum screening] |
Search more.